A promoter polymorphism of tumor necrosis factor α associated with systemic lupus erythematosus in African-Americans

Arthritis and Rheumatism

Volumn 40, Issue 12, 1997, Pages 2207-2211

  Sullivan, Kathleen E ^a,c   Wooten, Candra ^a   Schmeckpeper, Barbara J ^b   Goldman, Daniel ^b   Petri, Michelle A ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; PROMOTER REGION; RHEUMATIC DISEASE; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; DNA PRIMERS; FEMALE; GENE FREQUENCY; HLA-DR ANTIGENS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031470562     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780401215     Document Type: Article

References (39)

1. Rogers JA, Berman JW: TNF-α inhibits the further development of committed progenitors while stimulating multipotential progenitors in mouse long-term bone marrow cultures. J Immunol 153:4694-4703, 1994
2. Beutler B, Cerami A: The biology of cachectin/TNF-α primary mediator of the host response. Annu Rev Immunol 7:625-639, 1989
3. Pociot F, Briant L, Jongeneel CV, Molvig J, Worsaae H, Abbal M, Thomsen M, Nerup J, Cambon-Thomsen A: Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-α and TNF-β by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol 23:224-230, 1993
4. Elliott MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Katsikis P, Brennan FM, Walker J, Bijl H, Ghrayeb J, Woody JN: Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α. Arthritis Rheum 36:1681-1690, 1993
5. Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA, McDevitt HO: Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor α: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 87:1233-1237, 1990
6. Verjans GM, Messer G, Weiss EH, van der Linden SM, Kijlstra A: Polymorphism of the tumor necrosis factor region in relation to disease: an overview. Rheum Dis Clin North Am 18:177-186, 1992
7. Tomita Y, Hashimoto S, Yamagami K, Sawada S, Horie T: Restriction fragment length polymorphism (RFLP) analysis in the TNF genes of patients with systemic lupus erythematosus (SLE). Clin Exp Rheumatol 11:533-536, 1993
8. Udalova IA, Nedospasov SA, Webb GC, Chaplin DD, Turetskaya RL: Highly informative typing of the human TNF locus using six adjacent polymorphic markers. Genomics 16:180-186, 1993
9. Monos DS, Kamoun M, Udalova I, Csanky E, Cizman B, Turetskaya RL, Smirnova JB, Zharkov VG, Gasser D, Zmijewski CM, Spielman RS, Nedospasov SA: Genetic polymorphism of the human tumor necrosis factor region in insulin-dependent diabetes mellitus: linkage disequilibrium of TNFab microsatellite alleles with HLA haplotypes. Hum Immunol 44:70-79, 1995
10. Pociot F, D'Alfonso S, Compasso S, Scorza R, Richiardi PM: Functional analysis of a new polymorphism in the human TNF alpha gene promoter. Scand J Immunol 42:501-504, 1995
11. D'Alfonso S, Richiardi PM: A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics 39:150-154, 1994
12. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LB, Duff GW: An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 177:557-560, 1993
13. Galbraith GM, Pandey JP: Tumor necrosis factor alpha (TNF-alpha) gene polymorphism in alopecia areata. Hum Genet 96:433-436, 1995
14. Danis VA, Millington M, Hyland V, Lawford R, Huang Q, Grennan D: Increased frequency of the uncommon allele of a tumour necrosis factor alpha gene polymorphism in rheumatoid arthritis and systemic lupus erythematosus. Dis Markers 12:127-133, 1995
15. Messer G, Kick G, Ranki A, Koskimies S, Reunala T, Meurer M: Polymorphism of the tumor necrosis factor genes in patients with dermatitis herpetiformis. Dermatology 189 (suppl 1):135-137, 1994
16. Wilson AG, Gordon C, di Giovine FS, de Vries N, van de Putte LB, Emery P, Duff GW: A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha. Eur J Immunol 24:191-195, 1994
17. Danis VA, Millington M, Hyland VJ, Grennan D: Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol 99:303-310, 1995
18. Cabrera M, Shaw MA, Sharples C, Williams H, Castes M, Convit J, Blackwell JM: Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med 182: 1259-1264, 1995
19. McGuire W, Hill AVS, Allsopp CEM, Greenwood BM, Kwiatkowski D: Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 371:508-511, 1994
20. Abraham LJ, French MA, Dawkins RL: Polymorphic MHC ancestral haplotypes affect the activity of tumor necrosis factor-alpha. Clin Exp Immunol 92:14-18, 1993
21. Wilson AG, Symons JA, McDowell TL, di Giovine FS, Duff GW: Effects of a tumour necrosis factor promoter base transition on transcriptional activity (abstract). Br J Rheumatol 33 (suppl 1):89, 1994
22. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW: Effects of a polymorphism in the human tumor necrosis factor a promoter on transcriptional activation. Proc Natl Acad Sci U S A 94:3195-3199, 1997
23. Bias WB, Hochberg MC, McLean RH, Machan C: Systemic lupus erythematosus joint report. In, HLA 1991: Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Edited by K Tsuji, M Aizawa, T Sasazuki. Oxford, Oxford University Press, 1992
24. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277, 1982
25. Kunkel LM, Smith KD, Boyer SH, Borgaonkar DS, Wechtel SS, Miller OJ, Breg WR, Jones HW Jr, Rary JM: Analysis of human Y chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci U S A 74:1245-1249, 1977
26. Kimura A, Sasazuki T: Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique. In, HLA 1991. Edited by K Tsuji, M Aizawa, T Sasazuki. Oxford, Oxford University Press, 1992
27. Bignon JD, Fernandez-Vina M: Twelfth International Histocompatibility Workshop class II reference protocol. In, Proceedings of the 12th IHWC: Genetic Diversity of HLA, Functional and Medical Implications. Edited by D Charron, R Fauchet. Paris, EDK, 1997
28. Sullivan KE, Wooten C, Goldman D, Petri M: Mannose-binding protein genetic polymorphisms in black patients with systemic lupus erythematosus. Arthritis Rheum 39:2046-2051, 1996
29. Harley JB, Sheldon P, Neas B, Murphy S, Wallace DJ, Scofield RH, Shaver TS, Moser KL: Systemic lupus erythematosus: considerations for a genetic approach. J Invest Dermatol 103:144S-149S, 1994
30. Drake CG, Kotzin BL: Genetic and immunological mechanisms in the pathogenesis of systemic lupus erythematosus. Curr Opin Immunol 4:733-740, 1992
31. Arnett F, Reveille JD: Genetics of systemic lupus erythematosus. Rheum Dis Clin North Am 18:865-891, 1992
32. Drappa J, Vaishnaw AK, Sullivan KE, Chu J-L, Elkon KB: Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. N Engl J Med 335:1643-1649, 1996
33. Rieux-Laucat F, Le Diest F, Hivroz C, Roberts IAG, Debatin KM, Fischer A, de Villartay JP: Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268:1347-1350, 1995
34. Watanabe-Fukunuga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S: Lymphoproliferative disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314-317, 1992
35. Drake CG, Babcock SK, Palmer E, Kotzin BL: Genetic analysis of the NZB contribution to lupus-like autoimmune disease in (NZB × NZW) F1 mice. Proc Natl Acad Sci U S A 91:4062-4066, 1994
36. Drake CG, Rozzo SJ, Hirschfeld HF, Smarnworawong NP, Palmer E, Kotzin BL: Analysis of the New Zealand black contribution to lupus-like renal disease: multiple genes that operate in a threshold manner. J Immunol 154:2441-2447, 1995
37. Adebajo A, Davis P: Rheumatic diseases in African blacks. Semin Arthritis Rheum 24:139-153, 1994
38. Rudwaleit M, Tikly M, Khamashta M, Gibson K, Klinke J, Hughes G, Wordsworth P: Interethnic differences in the association of tumor necrosis factor promoter polymorphisms with systemic lupus erythematosus. J Rheumatol 23:1725-1728, 1996
39. Howard PF, Hochberg MC, Bias WB, Arnett FC, McLean RH: Relationship between C4 null genes, HLA-D region antigens, and genetic susceptibility to systemic lupus erythematosus in caucasian and black Americans. Am J Med 81:187-193, 1986